Diaphorina citri psyllid: psy8538

Annotation transfered from Closely Related SWISS-PROT Entries

Annotation	Function Description	Confidence Level	Reference Protein
Homeobox protein CDX-2	Involved in the transcriptional regulation of multiple genes expressed in the intestinal epithelium. Important in broad range of functions from early differentiation to maintenance of the intestinal epithelial lining of both the small and large intestine.	confident	Q99626
Homeobox protein CDX-1	Could play a role in the terminal differentiation of the intestine.	confident	P18111

Prediction of Gene Ontology Terms

GO Term	Description	Confidence Level	Parent GO Terms
GO:0048522 [BP]	positive regulation of cellular process	confident	GO:0048518, GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0006357 [BP]	regulation of transcription from RNA polymerase II promoter	confident	GO:0009889, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0010468
GO:0009948 [BP]	anterior/posterior axis specification	probable	GO:0032502, GO:0007389, GO:0032501, GO:0009952, GO:0044707, GO:0008150, GO:0003002, GO:0009798, GO:0007275, GO:0044699
GO:0000122 [BP]	negative regulation of transcription from RNA polymerase II promoter	probable	GO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0006357, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0045892, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0008150, GO:0010558, GO:0048523
GO:0008284 [BP]	positive regulation of cell proliferation	probable	GO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0000794 [CC]	condensed nuclear chromosome	probable	GO:0031974, GO:0043229, GO:0043228, GO:0000228, GO:0043227, GO:0043226, GO:0044446, GO:0031981, GO:0005634, GO:0005694, GO:0000793, GO:0043231, GO:0043232, GO:0043233, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0070013, GO:0044428, GO:0044424, GO:0044422
GO:0001568 [BP]	blood vessel development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0017053 [CC]	transcriptional repressor complex	probable	GO:0043234, GO:0044446, GO:0032991, GO:0005575, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0005654, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0044451, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0060711 [BP]	labyrinthine layer development	probable	GO:0032502, GO:0001701, GO:0044707, GO:0048568, GO:0032501, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0044699, GO:0009792, GO:0048731, GO:0043009, GO:0001892, GO:0007275, GO:0001890
GO:0005737 [CC]	cytoplasm	probable	GO:0044424, GO:0005575, GO:0044464, GO:0005623, GO:0005622
GO:0003714 [MF]	transcription corepressor activity	probable	GO:0003674, GO:0003712, GO:0000989, GO:0000988
GO:0045944 [BP]	positive regulation of transcription from RNA polymerase II promoter	probable	GO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0048103 [BP]	somatic stem cell division	probable	GO:0009987, GO:0008150, GO:0051301, GO:0044763, GO:0017145, GO:0044699
GO:0001756 [BP]	somitogenesis	probable	GO:0032502, GO:0007389, GO:0044699, GO:0032501, GO:0009952, GO:0044707, GO:0048856, GO:0007275, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0003002, GO:0043009, GO:0009653, GO:0035282, GO:0048646, GO:0061053
GO:0007443 [BP]	Malpighian tubule morphogenesis	probable	GO:0032502, GO:0061326, GO:0048619, GO:0055123, GO:0009790, GO:0048565, GO:0009653, GO:0007275, GO:0044699, GO:0002009, GO:0048513, GO:0048729, GO:0060562, GO:0048598, GO:0061333, GO:0032501, GO:0035239, GO:0060429, GO:0009888, GO:0044767, GO:0061525, GO:0008150, GO:0001655, GO:0072002, GO:0072001, GO:0007442, GO:0044707, GO:0048856, GO:0035295, GO:0048731, GO:0048546
GO:0002686 [BP]	negative regulation of leukocyte migration	probable	GO:0030336, GO:0040013, GO:0030334, GO:2000145, GO:0065007, GO:0051271, GO:0051270, GO:0008150, GO:0040012, GO:0002685, GO:0002682, GO:0002683, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0048704 [BP]	embryonic skeletal system morphogenesis	probable	GO:0048705, GO:0048598, GO:0009887, GO:0048562, GO:0044707, GO:0048513, GO:0009790, GO:0048568, GO:0032501, GO:0048856, GO:0044767, GO:0001501, GO:0048706, GO:0008150, GO:0009792, GO:0048731, GO:0043009, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0007350 [BP]	blastoderm segmentation	probable	GO:0032502, GO:0007389, GO:0032501, GO:0009880, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0008150, GO:0003002, GO:0035282, GO:0007275, GO:0044699
GO:0048793 [BP]	pronephros development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0001822, GO:0044767, GO:0048513, GO:0008150, GO:0001655, GO:0048731, GO:0072001, GO:0007275, GO:0044699
GO:0048384 [BP]	retinoic acid receptor signaling pathway	probable	GO:0044700, GO:0051716, GO:0030522, GO:0050896, GO:0009987, GO:0050794, GO:0008150, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0050789, GO:0044699
GO:0060349 [BP]	bone morphogenesis	probable	GO:0048705, GO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0048856, GO:0060348, GO:0044767, GO:0001501, GO:0048513, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0001889 [BP]	liver development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0061008, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0045446 [BP]	endothelial cell differentiation	probable	GO:0032502, GO:0060429, GO:0003158, GO:0030154, GO:0009888, GO:0008150, GO:0044763, GO:0048869, GO:0030855, GO:0009987, GO:0044699, GO:0048856
GO:0043065 [BP]	positive regulation of apoptotic process	probable	GO:0050794, GO:0050789, GO:0048518, GO:0043067, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0008333 [BP]	endosome to lysosome transport	probable	GO:0016197, GO:0051234, GO:0046907, GO:0007034, GO:0006810, GO:0044765, GO:0008150, GO:0007041, GO:0051649, GO:0044763, GO:0009987, GO:0051641, GO:0051179, GO:0044699, GO:0016482
GO:0006366 [BP]	transcription from RNA polymerase II promoter	probable	GO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0006351, GO:0019438
GO:0035019 [BP]	somatic stem cell maintenance	probable	GO:0030154, GO:0048468, GO:0050789, GO:0044699, GO:0048863, GO:0048864, GO:0048869, GO:0065007, GO:0048519, GO:0032502, GO:0032501, GO:0050793, GO:0009987, GO:0050794, GO:0044767, GO:0045596, GO:0045595, GO:0008150, GO:0051093, GO:0019827, GO:0044707, GO:0048856, GO:0044763, GO:0048523
GO:0007487 [BP]	analia development	probable	GO:0032502, GO:0035215, GO:0032501, GO:0044707, GO:0007444, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0008134 [MF]	transcription factor binding	probable	GO:0003674, GO:0005488, GO:0005515
GO:0045617 [BP]	negative regulation of keratinocyte differentiation	probable	GO:0051093, GO:0051239, GO:0050793, GO:0048519, GO:0050794, GO:0008150, GO:0045596, GO:0045595, GO:0065007, GO:0030856, GO:0030857, GO:0045605, GO:0045604, GO:0045683, GO:0045682, GO:0045616, GO:0050789, GO:0048523, GO:2000026
GO:0003705 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity	probable	GO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:2000738 [BP]	positive regulation of stem cell differentiation	probable	GO:2000736, GO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0045595, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0030054 [CC]	cell junction	probable	GO:0005575
GO:0001829 [BP]	trophectodermal cell differentiation	probable	GO:0032502, GO:0032501, GO:0001824, GO:0044707, GO:0009987, GO:0048869, GO:0001825, GO:0030154, GO:0044767, GO:0009790, GO:0001701, GO:0044763, GO:0048646, GO:0009792, GO:0008150, GO:0043009, GO:0009653, GO:0007275, GO:0044699, GO:0048856
GO:0007377 [BP]	germ-band extension	probable	GO:0048598, GO:0001703, GO:0048856, GO:0044707, GO:0032501, GO:0007369, GO:0044767, GO:0009790, GO:0010004, GO:0008150, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0007379 [BP]	segment specification	probable	GO:0032502, GO:0007389, GO:0032501, GO:0044707, GO:0008150, GO:0003002, GO:0035282, GO:0007275, GO:0044699
GO:0045656 [BP]	negative regulation of monocyte differentiation	probable	GO:0002761, GO:0051093, GO:0002762, GO:0045596, GO:0050793, GO:0050789, GO:0045655, GO:0050794, GO:1902105, GO:1902106, GO:0045638, GO:0065007, GO:0002682, GO:0008150, GO:0051239, GO:0048519, GO:2000026, GO:0045595, GO:0045637, GO:0048523
GO:0022603 [BP]	regulation of anatomical structure morphogenesis	probable	GO:0050793, GO:0008150, GO:0065007, GO:0050789
GO:0007420 [BP]	brain development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699, GO:0007417
GO:0031016 [BP]	pancreas development	probable	GO:0032502, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0007275, GO:0044699
GO:0001706 [BP]	endoderm formation	probable	GO:0032502, GO:0048598, GO:0007492, GO:0048856, GO:0044707, GO:0001704, GO:0007369, GO:0009888, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0044699, GO:0009653, GO:0007275, GO:0048646
GO:0005730 [CC]	nucleolus	probable	GO:0005575, GO:0043232, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0043228, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0001708 [BP]	cell fate specification	probable	GO:0032502, GO:0045165, GO:0048869, GO:0030154, GO:0044763, GO:0008150, GO:0009987, GO:0044699
GO:0060218 [BP]	hematopoietic stem cell differentiation	probable	GO:0032502, GO:0002376, GO:0048863, GO:0044707, GO:0048856, GO:0009987, GO:0048869, GO:0032501, GO:0030154, GO:0044767, GO:0048513, GO:0044763, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0001953 [BP]	negative regulation of cell-matrix adhesion	probable	GO:0010810, GO:0030155, GO:0001952, GO:0050794, GO:0050789, GO:0007162, GO:0065007, GO:0008150, GO:0048519, GO:0010812, GO:0048523
GO:0050673 [BP]	epithelial cell proliferation	probable	GO:0008150, GO:0044699, GO:0008283
GO:0048617 [BP]	embryonic foregut morphogenesis	probable	GO:0048598, GO:0032502, GO:0007440, GO:0048565, GO:0044707, GO:0048856, GO:0055123, GO:0007275, GO:0044767, GO:0009790, GO:0032501, GO:0008150, GO:0048731, GO:0009653, GO:0048546, GO:0044699
GO:0001077 [MF]	RNA polymerase II core promoter proximal region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription	probable	GO:0003700, GO:0001228, GO:0003674, GO:0001071, GO:0000982, GO:0000981
GO:0010870 [BP]	positive regulation of receptor biosynthetic process	probable	GO:0009893, GO:0019222, GO:0009891, GO:0060255, GO:0009889, GO:0031325, GO:0031323, GO:0010604, GO:0050794, GO:0010869, GO:0010557, GO:0010556, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0045197 [BP]	establishment or maintenance of epithelial cell apical/basal polarity	probable	GO:0035088, GO:0061245, GO:0009987, GO:0007163, GO:0044763, GO:0008150, GO:0044699
GO:0045647 [BP]	negative regulation of erythrocyte differentiation	probable	GO:0051093, GO:0050793, GO:0045646, GO:0045595, GO:0032844, GO:0050789, GO:0045596, GO:0045638, GO:0065007, GO:0002682, GO:0008150, GO:0051239, GO:0048519, GO:2000026, GO:0050794, GO:0045637, GO:0048523
GO:0000980 [MF]	RNA polymerase II distal enhancer sequence-specific DNA binding	probable	GO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0045639 [BP]	positive regulation of myeloid cell differentiation	probable	GO:0051094, GO:0050793, GO:0050794, GO:0045597, GO:0050789, GO:0045595, GO:0065007, GO:2000026, GO:0008150, GO:0051239, GO:0048518, GO:0002682, GO:0045637, GO:0048522
GO:0035224 [BP]	genital disc anterior/posterior pattern formation	probable	GO:0032502, GO:0007389, GO:0035215, GO:0048856, GO:0007447, GO:0009952, GO:0044707, GO:0007444, GO:0032501, GO:0007448, GO:0035221, GO:0044767, GO:0048513, GO:0008150, GO:0003002, GO:0048731, GO:0007275, GO:0044699
GO:0003690 [MF]	double-stranded DNA binding	probable	GO:0043566, GO:0097159, GO:0003674, GO:0005488, GO:0003676, GO:0003677, GO:1901363
GO:0021906 [BP]	hindbrain-spinal cord boundary formation	probable	GO:0021903, GO:0044707, GO:0021532, GO:0009790, GO:0009792, GO:0009653, GO:0007275, GO:0044699, GO:0007389, GO:0043009, GO:0048646, GO:0032502, GO:0032501, GO:0021915, GO:0044767, GO:0008150, GO:0003002, GO:0048859, GO:0009952, GO:0007399, GO:0048856, GO:0048731

Prediction of Enzyme Commission Number

No EC number assigned to the protein, probably not an enzyme!

Spatial Structural Prediction